lansoprazole has been researched along with Liver Neoplasms in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this work was to assess the gastroprotective effect of amino acid amides from imbricatolic acid and its 8(9)-en isomer in the ethanol/HCl-induced gastric lesions model in mice as well as to determine the cytotoxicity of the obtained compounds on the following human cell lines: normal lung fibroblasts (MRC-5), gastric adenocarcinoma (AGS), and liver hepatocellular carcinoma (Hep G2)." | 3.77 | Gastroprotective effect and cytotoxicity of labdeneamides with amino acids. ( RodrÃguez, JA; Schmeda-Hirschmann, G; Theoduloz, C; Valderrama, JA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmeda-Hirschmann, G | 1 |
| RodrÃguez, JA | 1 |
| Theoduloz, C | 1 |
| Valderrama, JA | 1 |
| Kikuchi, H | 1 |
| Kato, H | 1 |
| Mizuno, M | 1 |
| Hossain, A | 1 |
| Ikawa, S | 1 |
| Miyazaki, J | 1 |
| Watanabe, M | 1 |
2 other studies available for lansoprazole and Liver Neoplasms
| Article | Year |
|---|---|
Gastroprotective effect and cytotoxicity of labdeneamides with amino acids.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Amides; Amino Acids; Animals; Anti-Ulcer Ag | 2011 |
Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Carcinoma, Hepatocellular; Cell Li | 1996 |